STENHOUSE MARK received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/24/2024ACC: 0000950170-24-064813
Director
Since Mar 2020
-7K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
10.50K acquired · 17.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.50K
Price / share
—
Trade value
—
% of position
116.7%
5/23/2024
9K→19.50K
Total
Net shares
+10.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/23/2024 | A · Award | +10.50K | — | — | 116.7% | 9K | 19.50K |
| Total | +10.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
17.50K shares
Shares
−17.50K
Strike price
10.30
Held after
17.50K
Exercisable
—
5/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock17.50K shares | 5/23/2024 | A · Award | −17.50K | 10.30 | — | 17.50K |